COO logo

Cooper Cos Inc (COO)$62.55

Market Cap: 16.31 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Cooper Cos Inc (COO).

HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
DCF ready

Valuation

37.4x

EV/FCF, 2.7% FCF yield

Quality

4.6%

ROIC, 10.6% FCF margin

Growth

11.0%

5Y sales (revenue) CAGR

Balance sheet

0.0x

Debt/equity, 1.9x current ratio

Superinvestors

1

Top: Torray Funds (0.3%)

Strengths to research

  • Revenue compounded at 11.0% over five years.
  • Free cash flow compounded at 19.7% over five years.
  • Debt/equity looks manageable at 0.0x.
  • 10 annual periods are available for trend analysis.

Watchouts

  • P/FCF is elevated at 37.6x.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for COO.

Grade C
55
/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
COO
Target
Cooper Cos Inc$16.3B33.4x37.4x4.6%11.0%10.6%65.5%-0.1xN/A
BAXBaxter International Inc.$15.6B-10.3x69.5x-6.1%-0.7%3.0%30.1%11.1xN/A
ALGNAlign Technology Inc.$13.0B29.0x24.3x10.1%10.3%12.2%67.2%-1.4xN/A
HOLXHologic Inc.$11.8BN/AN/AN/AN/AN/AN/AN/AN/A
SOLVSolventum Corp$11.6B8.7x-1572.9x15.4%N/A-0.1%53.5%1.6xN/A
AVTRAvantor arinc.$8.6B-10.4x24.6x-5.6%0.5%7.6%32.7%N/AN/A
RGENRepligen Corp.$7.9B133.8x84.1x1.8%N/AN/AN/A-0.3xN/A
RMDResMed Inc.$35.3B21.9x20.9x21.1%11.7%32.3%59.4%-0.3xN/A
BDXBecton Dickinson$47.9B25.4x17.7x6.6%6.3%12.2%N/A-0.1xN/A

Financial Charts

No financial data available for COO (annual).

1 superinvestors own COO

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Torray Funds

Torray Funds

25,435$2M0.29%0.0%